COVID-19 Vaccine Information

This Is Important

For the foreseeable future, everyone—including those who were vaccinated—must continue to practice protective behaviors including wearing a face covering, physical distancing, following testing protocols, avoiding nonessential travel, and other measures. This is important since it is not yet known if the vaccines protect against asymptomatic infection and consequently prevent transmission to others. In addition, it will take time to achieve high vaccine uptake (estimated at 70-80%) to achieve herd immunity, i.e., sufficient population-level protection from transmission of the virus.  

How to Get Vaccinated in New York

Visit COVID-19 Vaccine Finder. Or call one of these numbers: for New York City, dial (877) VAX- 4NYC (1-877-829-4692); for elsewhere in New York State, dial (833) NYS-4-VAX (1-833-697-4829).


Frequently Asked Questions

Which vaccines have been authorized for use in the United States?

There are currently three vaccines that have received Emergency Use Authorization (EUA) by the U.S. Federal Drug Administration (FDA). These include the Pfizer BioNTech vaccine, the Moderna vaccine, and the Johnson & Johnson's Janssen vaccine. Read more.

How do the vaccines work?

The Moderna and Pfizer vaccines use genetic material known as messenger RNA that instructs the body's cells to make a protein that stimulates the immune system to produce antibodies to fight the virus. The Johnson & Johnson vaccine uses the more traditional virus-based technology. Read more.

When will the vaccines be available to the public and who will receive it?

The vaccines are currently being distributed to various states, and Columbia is monitoring the situation. Check the New York State eligibility website for the latest information. Read more.

Vaccine-related Announcements

Vaccination Video

Aerial view of Columbia University Irving Medical center campus

The Pfizer/BioNTech and Moderna COVID-19 vaccines are being administered to front-line health care personnel at CUIMC. Read about the rollout.